Stable pharmaceutical formulations of methylnaltrexone

作者: Thomas A. Boyd , Suketu P. Sanghvi

DOI:

关键词: MethylnaltrexoneCombinatorial chemistryChemistry

摘要: Stable pharmaceutical compositions useful for administering methylnaltrexone are described, as methods making the same. Kits, including these compositions, also provided.

参考文章(597)
Bob Van Gemen, Anthonij de Ronde, Eveline Catherina A. C. Timmermans, Irene Johanna M. Dobbelaer, Method of determining therapeutic activity and/or possible side-effects of a medicament ,(2001)
Jeffrey Alan Dodge, Henry Uhlman Bryant, George Joseph Cullinan, METHODS FOR INHIBITING DETRIMENTAL SIDE-EFFECTS DUE TO GnRH OR GnRH AGONIST ADMINISTRATION ,(1998)
M J Kreek, D M Novick, V Ghali, M Ochshorn, N Chiorazzi, T S Croxson, W D Mercer, Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. Journal of Pharmacology and Experimental Therapeutics. ,vol. 250, pp. 606- 610 ,(1989)
L Heucke, R M Arendt, A Plasse, K Werdan, U Wilbert-Lampen, M Schmoeckel, Bidirectional effects of endogenous opioid peptides on endothelin release rates in porcine aortic endothelial cell culture: mediation by delta opioid receptor and opioid receptor antagonist-insensitive mechanisms. Journal of Pharmacology and Experimental Therapeutics. ,vol. 272, pp. 1- 7 ,(1995)
Kadum A. Al Shareffi, Eric C. Ehrnsperger, Christopher Richard Diorio, Jonathan Marc Cohen, Xu Meng, Syed M. Shah, Oral formulations and lipophilic salts of methylnaltrexone ,(2011)
Kersten Walter, Thomas Profitlich, Galenic composition containing opioid antagonists ,(1997)
Philip S. Portoghese, Gut-selective opiates ,(1985)
Tomoaki Kimoto, Haruo Honda, Noriko Saito, Fujio Nakagame, Teppei Maruyama, Pharmaceutical composition containing urokinase ,(1984)